These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 30860027
21. [MicroRNA-34a regulates cell cycle by targeting CD44 in human bladder carcinoma cells]. Yu G, Xu K, Xu S, Zhang X, Huang Q, Lang B. Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jul; 35(7):935-40. PubMed ID: 26198939 [Abstract] [Full Text] [Related]
22. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T, Ito M. Biochem Biophys Res Commun; 2008 Dec 05; 377(1):114-9. PubMed ID: 18834855 [Abstract] [Full Text] [Related]
23. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a. Liang J, Li Y, Daniels G, Sfanos K, De Marzo A, Wei J, Li X, Chen W, Wang J, Zhong X, Melamed J, Zhao J, Lee P. Mol Cancer Res; 2015 Apr 05; 13(4):681-8. PubMed ID: 25587085 [Abstract] [Full Text] [Related]
24. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Yang S, Li Y, Gao J, Zhang T, Li S, Luo A, Chen H, Ding F, Wang X, Liu Z. Oncogene; 2013 Sep 05; 32(36):4294-303. PubMed ID: 23001043 [Abstract] [Full Text] [Related]
25. Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells. Chandrasekaran KS, Sathyanarayanan A, Karunagaran D. Tumour Biol; 2016 Oct 05; 37(10):13155-13166. PubMed ID: 27456356 [Abstract] [Full Text] [Related]
26. Expression of microRNA miR-34a inhibits leukemia stem cells and its metastasis. Wang S, Wang T, Li MZ, Cheng XL, Li XL. Eur Rev Med Pharmacol Sci; 2016 Jul 05; 20(13):2878-83. PubMed ID: 27424989 [Abstract] [Full Text] [Related]
27. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway. Chang YL, Zhou PJ, Wei L, Li W, Ji Z, Fang YX, Gao WQ. Oncotarget; 2015 Sep 15; 6(27):24017-31. PubMed ID: 26172296 [Abstract] [Full Text] [Related]
28. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL. Br J Cancer; 2008 Feb 26; 98(4):756-65. PubMed ID: 18268494 [Abstract] [Full Text] [Related]
29. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. Cancer Res; 2007 Jul 15; 67(14):6796-805. PubMed ID: 17638891 [Abstract] [Full Text] [Related]
30. miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44. Zhao H, Ma B, Wang Y, Han T, Zheng L, Sun C, Liu T, Zhang Y, Qiu X, Fan Q. Oncol Rep; 2013 Mar 15; 29(3):1027-36. PubMed ID: 23314380 [Abstract] [Full Text] [Related]
31. EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells. Jiang P, Xu C, Chen L, Chen A, Wu X, Zhou M, Haq IU, Mariyam Z, Feng Q. Mol Carcinog; 2018 Dec 15; 57(12):1835-1844. PubMed ID: 30182373 [Abstract] [Full Text] [Related]
32. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Östling P, Leivonen SK, Aakula A, Kohonen P, Mäkelä R, Hagman Z, Edsjö A, Kangaspeska S, Edgren H, Nicorici D, Bjartell A, Ceder Y, Perälä M, Kallioniemi O. Cancer Res; 2011 Mar 01; 71(5):1956-67. PubMed ID: 21343391 [Abstract] [Full Text] [Related]
33. MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer. Bucay N, Sekhon K, Yang T, Majid S, Shahryari V, Hsieh C, Mitsui Y, Deng G, Tabatabai ZL, Yamamura S, Calin GA, Dahiya R, Tanaka Y, Saini S. Oncogene; 2017 May 11; 36(19):2667-2679. PubMed ID: 27893706 [Abstract] [Full Text] [Related]
34. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1. Xie ZY, Wang FF, Xiao ZH, Liu SF, Tang SL, Lai YL. J Biochem; 2020 Jun 01; 167(6):557-564. PubMed ID: 32044957 [Abstract] [Full Text] [Related]
35. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression. Chakravarthi BVSK, Chandrashekar DS, Agarwal S, Balasubramanya SAH, Pathi SS, Goswami MT, Jing X, Wang R, Mehra R, Asangani IA, Chinnaiyan AM, Manne U, Sonpavde G, Netto GJ, Gordetsky J, Varambally S. Mol Cancer Res; 2018 Jul 01; 16(7):1125-1137. PubMed ID: 29025958 [Abstract] [Full Text] [Related]
36. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy. Gaur S, Wen Y, Song JH, Parikh NU, Mangala LS, Blessing AM, Ivan C, Wu SY, Varkaris A, Shi Y, Lopez-Berestein G, Frigo DE, Sood AK, Gallick GE. Oncotarget; 2015 Oct 06; 6(30):29161-77. PubMed ID: 26313360 [Abstract] [Full Text] [Related]
37. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue YF, Li G, Lu X, Sun Z, Tang KF. Carcinogenesis; 2012 Mar 06; 33(3):519-28. PubMed ID: 22198213 [Abstract] [Full Text] [Related]
38. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a. Huang X, Xie X, Wang H, Xiao X, Yang L, Tian Z, Guo X, Zhang L, Tang H, Xie X. J Exp Clin Cancer Res; 2017 Sep 15; 36(1):129. PubMed ID: 28915924 [Abstract] [Full Text] [Related]
39. MicroRNA-34a-mediated death of acute myeloid leukemia stem cells through apoptosis induction and exosome shedding inhibition via histone deacetylase 2 targeting. Hu Y, Ma X, Wu Z, Nong Q, Liu F, Wang Y, Dong M. IUBMB Life; 2020 Jul 15; 72(7):1481-1490. PubMed ID: 32181973 [Abstract] [Full Text] [Related]
40. Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells. Zhu M, Zheng Z, Huang J, Ma X, Huang C, Wu R, Li X, Liang Z, Deng F, Wu J, Geng S, Xie C, Zhong C. J Cell Biochem; 2019 Sep 15; 120(9):15616-15624. PubMed ID: 31042325 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]